Atlas Trials

Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

Clinical trial NCT05086250 · COMPLETED

Trial details

NCT number
NCT05086250
Sponsor
Cedars-Sinai Medical Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
AnxietyPancreatic Cancer
Start date
2022-10-20
Primary completion
2026-03-06
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.